We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
128 hedge funds and large institutions have $1.11B invested in Intra-Cellular Therapies Inc. in 2015 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
463% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 8
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
93% more capital invested
Capital invested by funds: $576M → $1.11B (+$538M)
42% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 31
41% more funds holding
Funds holding: 91 → 128 (+37)
27% more call options, than puts
Call options by funds: $22.1M | Put options by funds: $17.5M
Holders
128
Holders Change
+37
Holders Change %
+40.66%
% of All Funds
3.57%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
45
Increased
44
Reduced
31
Closed
8
Calls
$22.1M
Puts
$17.5M
Net Calls
+$4.68M
Net Calls Change
+$280K
Top Buyers
| 1 |
TCM
TimesSquare Capital Management
New York
|
+$35.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$34M |
| 3 |
State Street
Boston,
Massachusetts
|
+$28.7M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$23.2M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$16.5M |
